{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:24:52Z","timestamp":1791469492218,"version":"4.3.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Cancer Research UK Programme","award":["C8162\/A29083"],"award-info":[{"award-number":["C8162\/A29083"]}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["G-001522, MGU0461"],"award-info":[{"award-number":["G-001522, MGU0461"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF22OC0076184"],"award-info":[{"award-number":["NNF22OC0076184"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study examined whether breast cancer survival improvements with screening are explained solely by detection at early stages and whether mortality can be predicted using stage and diagnosis date alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared stage-specific net survival between never-screened, symptomatic ever-screened (past attenders and interval cancers), and screen-detected breast cancer cases in Denmark using individual-level electronic health records from January 1, 2010 to December 31, 2022. Lifetables were generated from women without breast cancer, separately for never-screened and ever-screened women. Age-specific all-cause mortality rates were used to calculate excess mortality in women with breast cancer, which was then transformed into net survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 817\u00a0128 women, 32\u00a0827 had breast cancer, with 8% presenting as stage III or IV. Survival differences between symptomatic and screen-detected cases were minimal for stages I\u2013III but reached 40% at stage IV, with 5-year net survival for stage IV screen-detected women (74.7%) resembling stage IIIc symptomatic survival in never-screened women (72.6%). Survival from stage IV breast cancer was strongly associated with treatment, with median survival (years) of 4.4-6.0 with surgery, 1.6-2.2 with nonsurgical treatment, and 0.03-0.13 with no treatment; 67% of screen-detected patients received surgery (compared with 23% of never-screened and 27% of symptomatic ever-screened).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Greater survival in screen-detected stage IV cases suggests that breast cancer screening may not have come too late and deserves to be investigated further. Predicting breast cancer mortality using stage at diagnosis and stage-specific survival (without differentiating by route to diagnosis) will underestimate the impact of breast screening on mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djaf377","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:37:23Z","timestamp":1768567043000},"page":"1073-1080","source":"Crossref","is-referenced-by-count":3,"title":["Improved stage-specific survival in screen-detected breast cancer in Denmark: a cohort study"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8246-0702","authenticated-orcid":false,"given":"Amy","family":"Tickle","sequence":"first","affiliation":[{"name":"Comprehensive Cancer Centre, King\u2019s College London, Guy\u2019s Campus , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5604-1635","authenticated-orcid":false,"given":"Judith","family":"Offman","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Queen Mary University of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9504-2294","authenticated-orcid":false,"given":"Bernard","family":"North","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Queen Mary University of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4534-0351","authenticated-orcid":false,"given":"Susanne Fogh","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Regional Health Research, University of Southern Denmark , Odense,","place":["Denmark"]},{"name":"Research Unit for Screening and Epidemiology, Department for Biochemistry and Immunology, University Hospital of Southern Denmark , Vejle,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0429-4176","authenticated-orcid":false,"given":"Sisse","family":"Njor","sequence":"additional","affiliation":[{"name":"Department of Regional Health Research, University of Southern Denmark , Odense,","place":["Denmark"]},{"name":"Research Unit for Screening and Epidemiology, Department for Biochemistry and Immunology, University Hospital of Southern Denmark , Vejle,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-8744","authenticated-orcid":false,"given":"Peter","family":"Sasieni","sequence":"additional","affiliation":[{"name":"Wolfson Institute of Population Health, Queen Mary University of London , London,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2026060902514724400_djaf377-B1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"2026060902514724400_djaf377-B2","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial","volume":"21","author":"Duffy","year":"2020","journal-title":"Lancet Oncol"},{"key":"2026060902514724400_djaf377-B3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M19-2125","article-title":"Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines","volume":"172","author":"Sch\u00fcnemann","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026060902514724400_djaf377-B4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.breast.2022.04.003","article-title":"Global guidelines for breast cancer screening: a systematic review","volume":"64","author":"Ren","year":"2022","journal-title":"Breast"},{"key":"2026060902514724400_djaf377-B5","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1038\/bjc.2015.49","article-title":"Stage at diagnosis and early mortality from cancer in England","volume":"112 Suppl 1","author":"McPhail","year":"2015","journal-title":"Br J Cancer"},{"key":"2026060902514724400_djaf377-B6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026060902514724400_djaf377-B7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-023-07219-0","article-title":"Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain","volume":"205","author":"J\u00f8rgensen","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"2026060902514724400_djaf377-B8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/CLEP.S99467","article-title":"Danish Quality Database for Mammography Screening","volume":"8","author":"Mikkelsen","year":"2016","journal-title":"Clin Epidemiol"},{"key":"2026060902514724400_djaf377-B9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026060902514724400_djaf377-B10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026060902514724400_djaf377-B11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/CLEP.S9908","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank","volume":"2","author":"Erichsen","year":"2010","journal-title":"Clin Epidemiol"},{"key":"2026060902514724400_djaf377-B12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2026060902514724400_djaf377-B13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2026060902514724400_djaf377-B14","first-page":"101","article-title":"The relative survival rate: a statistical methodology","volume":"6","author":"Ederer","year":"1961","journal-title":"Natl Cancer Inst Monogr"},{"key":"2026060902514724400_djaf377-B15","author":"Papanicolaou"},{"key":"2026060902514724400_djaf377-B16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1186\/s12885-016-2967-9","article-title":"Analysing population-based cancer survival\u2014settling the controversies","volume":"16","author":"Pohar Perme","year":"2016","journal-title":"BMC Cancer"},{"key":"2026060902514724400_djaf377-B17","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41416-020-0739-4","article-title":"Errors in determination of net survival: cause-specific and relative survival settings","volume":"122","author":"Bright","year":"2020","journal-title":"Br J Cancer"},{"key":"2026060902514724400_djaf377-B18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.bjc.6604368","article-title":"Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?","volume":"98","author":"Wishart","year":"2008","journal-title":"Br J Cancer"},{"key":"2026060902514724400_djaf377-B19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/bjc.2011.144","article-title":"Explaining the difference in prognosis between screen-detected and symptomatic breast cancers","volume":"104","author":"Allgood","year":"2011","journal-title":"British Journal of Cancer"},{"key":"2026060902514724400_djaf377-B20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/bjc.2016.290","article-title":"Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study","volume":"115","author":"Landy","year":"2016","journal-title":"Br J Cancer"},{"key":"2026060902514724400_djaf377-B21","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.2024.5814","article-title":"Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening: a systematic review and meta-analysis","volume":"331","author":"Feng","year":"2024","journal-title":"JAMA"},{"key":"2026060902514724400_djaf377-B22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1055-9965.EPI-22-0024","article-title":"Stage shift as an endpoint in cancer screening trials: implications for evaluating multicancer early detection tests","volume":"31","author":"Owens","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026060902514724400_djaf377-B23","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1245\/s10434-013-2998-2","article-title":"Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival","volume":"20","author":"Harris","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2026060902514724400_djaf377-B24","first-page":"349","article-title":"Role of surgery in metastatic breast cancer: insights from a narrative review","volume":"15","author":"Alghamdi","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"2026060902514724400_djaf377-B25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/SLA.0000000000002621","article-title":"Surgical resection of the primary tumor in women with de novo stage IV breast cancer: contemporary practice patterns and survival analysis","volume":"269","author":"Lane","year":"2019","journal-title":"Ann Surg"},{"key":"2026060902514724400_djaf377-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oncolo\/oyad266","article-title":"Impact of primary breast surgery on overall survival of patients with de novo metastatic breast cancer: a systematic review and meta-analysis","volume":"29","author":"Villacampa","year":"2024","journal-title":"Oncologist"},{"key":"2026060902514724400_djaf377-B27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1186\/s12885-022-10098-1","article-title":"Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes\u2014an observational cohort study in Sweden","volume":"22","author":"Lindman","year":"2022","journal-title":"BMC Cancer"},{"key":"2026060902514724400_djaf377-B28","doi-asserted-by":"crossref","first-page":"S503","DOI":"10.1016\/j.annonc.2021.08.600","article-title":"Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease","volume":"32","author":"Marin Zafra","year":"2021","journal-title":"Ann Oncol."},{"key":"2026060902514724400_djaf377-B29","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1245\/s10434-021-10227-3","article-title":"Survival outcomes among patients with metastatic breast cancer: review of 47,000 patients","volume":"28","author":"Taskindoust","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026060902514724400_djaf377-B30","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1245\/s10434-021-09621-8","article-title":"The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (protocol BOMET MF 14-01): a multi-center, prospective registry study","volume":"28","author":"Soran","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026060902514724400_djaf377-B31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.breast.2020.08.015","article-title":"Self-reported symptoms among participants in a population-based screening program","volume":"54","author":"Larsen","year":"2020","journal-title":"Breast"},{"key":"2026060902514724400_djaf377-B32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"1985","journal-title":"N Engl J Med"},{"key":"2026060902514724400_djaf377-B33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.mric.2017.12.001","article-title":"Breast MR imaging: atlas of anatomy, physiology, pathophysiology, and breast imaging reporting and data systems lexicon","volume":"26","author":"Martaindale","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"2026060902514724400_djaf377-B34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-018-4877-9","article-title":"Screening status, tumour subtype, and breast cancer survival: a national population-based analysis","volume":"172","author":"O\u2019Brien","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2026060902514724400_djaf377-B35","doi-asserted-by":"crossref","first-page":"e074684","DOI":"10.1136\/bmj-2022-074684","article-title":"Breast cancer mortality in 500\u2009000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study","volume":"381","author":"Taylor","year":"2023","journal-title":"BMJ."},{"key":"2026060902514724400_djaf377-B36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0969141312474443","article-title":"Excess all-cause mortality in the evaluation of a screening trial to account for selective participation","volume":"20","author":"Kranse","year":"2013","journal-title":"J Med Screen"},{"key":"2026060902514724400_djaf377-B37","author":"Statistics Denmark"},{"key":"2026060902514724400_djaf377-B38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/bjc.2013.6","article-title":"Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study","volume":"108","author":"Walters","year":"2013","journal-title":"Br J Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/6\/1073\/66967612\/djaf377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/6\/1073\/66967612\/djaf377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:51:59Z","timestamp":1780987919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/6\/1073\/8489198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf377","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,2,19]]}}}